IL22 and allergic asthma: Furthermore, we demonstrate that treatment of sensitized wild type mice with recombinant IL-22 before allergen exposure can reduce the development of AHR and airway inflammation, suggesting that exploiting this pathway could provide a potential therapeutic avenue for the treatment of allergic asthma.